Filing Details
- Accession Number:
- 0001127602-11-016617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-17 15:10:28
- Reporting Period:
- 2011-05-13
- Filing Date:
- 2011-05-17
- Accepted Time:
- 2011-05-17 15:10:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1229291 | Iii Samuel F Eberts | 531 South Spring Street Burlington NC 27215 | Chief Legal Officer, Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-13 | 10,000 | $80.37 | 27,542 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-05-13 | 5,200 | $75.63 | 32,742 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-13 | 15,200 | $99.04 | 17,542 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2011-05-13 | 10,000 | $0.00 | 10,000 | $80.37 |
| Common Stock | Non-qualified Stock Options | Disposition | 2011-05-13 | 5,200 | $0.00 | 5,200 | $75.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2008-02-20 | 2017-02-20 | No | 4 | M | Direct |
| 9,200 | 2009-05-07 | 2018-05-07 | No | 4 | M | Direct |
Footnotes
- The price of $99.0447 per share represents a weighted average of sales prices ranging from $98.95 to $99.36 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Common stock purchase option granted under the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan.
- The option vested in three equal annual installments beginning on 02/20/2008 and is now fully exercisable.
- The option vested in three equal annual installments beginning on 05/07/2009 and is now fully exercisable.
Billionaire Hedge Funds
